| RS132630276 |
WAS
|
Health Risk |
Pathogenic |
THROMBOCYTOPENIA, X-LINKED |
| RS132630277 |
TAFAZZIN
|
Health Risk |
Pathogenic/Likely pathogenic |
3-Methylglutaconic aciduria type 2, TAFAZZIN-related disorder |
| RS132630278 |
PLP1
|
Health Risk |
Pathogenic |
Pelizaeus-Merzbacher disease, Pelizaeus-Merzbacher disease |
| RS132630279 |
PLP1
|
Health Risk |
Likely pathogenic |
Pelizaeus-Merzbacher disease, Pelizaeus-Merzbacher disease |
| RS132630280 |
PLP1
|
Health Risk |
Pathogenic |
Pelizaeus-Merzbacher disease, Pelizaeus-Merzbacher disease |
| RS132630281 |
PLP1
|
Health Risk |
Likely pathogenic |
Pelizaeus-Merzbacher disease, Pelizaeus-Merzbacher disease |
| RS132630282 |
PLP1
|
Health Risk |
Pathogenic |
Pelizaeus-Merzbacher disease, Pelizaeus-Merzbacher disease |
| RS132630284 |
PLP1
|
Health Risk |
Pathogenic |
Pelizaeus-Merzbacher disease, Pelizaeus-Merzbacher disease |
| RS132630285 |
PLP1
|
Health Risk |
Pathogenic |
Pelizaeus-Merzbacher disease, Pelizaeus-Merzbacher disease |
| RS132630286 |
PLP1
|
Health Risk |
Pathogenic |
Pelizaeus-Merzbacher disease, connatal |
| RS132630288 |
PLP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 2, Pelizaeus-Merzbacher disease |
| RS132630289 |
PLP1
|
Health Risk |
Likely pathogenic |
Pelizaeus-Merzbacher disease, Pelizaeus-Merzbacher disease |
| RS132630290 |
PLP1
|
Health Risk |
Pathogenic |
Pelizaeus-Merzbacher disease, mild |
| RS132630291 |
PLP1
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 2, Pelizaeus-Merzbacher disease |
| RS132630292 |
PLP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Pelizaeus-Merzbacher disease, atypical |
| RS132630293 |
PLP1
|
Health Risk |
Pathogenic |
Pelizaeus-Merzbacher disease, connatal |
| RS132630294 |
PLP1
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 2, Hereditary spastic paraplegia 2 |
| RS132630295 |
PLP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 2, Pelizaeus-Merzbacher disease |
| RS132630296 |
PLP1
|
Health Risk |
Pathogenic |
Pelizaeus-Merzbacher disease, Pelizaeus-Merzbacher disease |
| RS132630297 |
PHF6
|
Health Risk |
Pathogenic |
Borjeson-Forssman-Lehmann syndrome, Intellectual disability |
| RS132630298 |
PHF6
|
Health Risk |
Pathogenic |
Borjeson-Forssman-Lehmann syndrome, Borjeson-Forssman-Lehmann syndrome |
| RS132630299 |
PHF6
|
Health Risk |
Pathogenic |
Borjeson-Forssman-Lehmann syndrome, Borjeson-Forssman-Lehmann syndrome |
| RS132630300 |
PHF6
|
Health Risk |
Pathogenic |
Borjeson-Forssman-Lehmann syndrome, Hereditary spastic paraplegia 4 |
| RS132630301 |
PHF6
|
Health Risk |
Pathogenic |
Borjeson-Forssman-Lehmann syndrome, Borjeson-Forssman-Lehmann syndrome |
| RS132630302 |
MTM1
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe X-linked myotubular myopathy, Severe X-linked myotubular myopathy |
| RS132630303 |
MTM1
|
Health Risk |
Pathogenic |
Severe X-linked myotubular myopathy, Severe X-linked myotubular myopathy |
| RS132630304 |
MTM1
|
Health Risk |
Pathogenic |
Severe X-linked myotubular myopathy, Centronuclear myopathy |
| RS132630305 |
MTM1
|
Health Risk |
Pathogenic |
Severe X-linked myotubular myopathy, Severe X-linked myotubular myopathy |
| RS132630306 |
MTM1
|
Health Risk |
Pathogenic |
Severe X-linked myotubular myopathy, Centronuclear myopathy |
| RS132630307 |
MTM1
|
Health Risk |
Likely pathogenic |
Severe X-linked myotubular myopathy, Severe X-linked myotubular myopathy |
| RS132630308 |
EDA
|
Health Risk |
Likely pathogenic |
Hypohidrotic X-linked ectodermal dysplasia, Tooth agenesis |
| RS132630309 |
EDA
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypohidrotic X-linked ectodermal dysplasia, EDA-related disorder |
| RS132630310 |
EDA
|
Health Risk |
Pathogenic |
Hypohidrotic X-linked ectodermal dysplasia, Hypohidrotic X-linked ectodermal dysplasia |
| RS132630311 |
EDA
|
Health Risk |
Likely pathogenic |
Hypohidrotic X-linked ectodermal dysplasia, Hypohidrotic X-linked ectodermal dysplasia |
| RS132630312 |
EDA
|
Health Risk |
Pathogenic |
Hypohidrotic X-linked ectodermal dysplasia, Tooth agenesis |
| RS132630313 |
EDA
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypohidrotic X-linked ectodermal dysplasia, EDA-related disorder |
| RS132630314 |
EDA
|
Health Risk |
Pathogenic |
Hypohidrotic X-linked ectodermal dysplasia, Tooth agenesis |
| RS132630315 |
EDA
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypohidrotic X-linked ectodermal dysplasia, Hypohidrotic X-linked ectodermal dysplasia |
| RS132630316 |
EDA
|
Health Risk |
Pathogenic |
Hypohidrotic X-linked ectodermal dysplasia, Hypohidrotic X-linked ectodermal dysplasia |
| RS132630317 |
EDA
|
Health Risk |
Likely pathogenic |
Hypohidrotic X-linked ectodermal dysplasia, Hypohidrotic X-linked ectodermal dysplasia |
| RS132630318 |
EDA
|
Health Risk |
Pathogenic |
Hypohidrotic X-linked ectodermal dysplasia, Hypohidrotic X-linked ectodermal dysplasia |
| RS132630319 |
EDA
|
Health Risk |
Pathogenic |
Tooth agenesis, selective |
| RS132630320 |
EDA
|
Health Risk |
Pathogenic |
Tooth agenesis, selective |
| RS132630321 |
EDA
|
Health Risk |
Pathogenic |
Tooth agenesis, selective |
| RS132630322 |
NHS
|
Health Risk |
Pathogenic |
Nance-Horan syndrome, Cataract 40 |
| RS132630323 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS132630324 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS132630325 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS132630326 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS132630327 |
NR0B1
|
Health Risk |
Pathogenic |
Mineralocorticoid deficiency, isolated |
| RS132630328 |
GK
|
Health Risk |
Pathogenic |
Inborn glycerol kinase deficiency, Inborn glycerol kinase deficiency |
| RS132630329 |
GK
|
Health Risk |
Pathogenic |
Inborn glycerol kinase deficiency, Inborn glycerol kinase deficiency |
| RS132630330 |
GK
|
Health Risk |
Pathogenic |
Inborn glycerol kinase deficiency, Inborn glycerol kinase deficiency |
| RS132630331 |
GK
|
Health Risk |
Pathogenic |
Inborn glycerol kinase deficiency, Inborn glycerol kinase deficiency |
| RS1326313565 |
NFIX
|
Health Risk |
Pathogenic |
Malan overgrowth syndrome, Malan overgrowth syndrome |
| RS1326321652 |
ALK
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuroblastoma, susceptibility to |
| RS1326330706 |
TRIM37
|
Health Risk |
Pathogenic/Likely pathogenic |
Mulibrey nanism syndrome, Mulibrey nanism syndrome |
| RS1326332740 |
ODAD1
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1326359185 |
SACS
|
Health Risk |
Likely pathogenic |
Charlevoix-Saguenay spastic ataxia, Charlevoix-Saguenay spastic ataxia |
| RS1326361967 |
CYBA
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS1326370032 |
EYS
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 25, Retinitis pigmentosa |
| RS1326382443 |
FANCG
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia, Fanconi anemia complementation group G |
| RS1326389765 |
ABCC9
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Cardiovascular phenotype |
| RS1326401124 |
LAMA2
|
Health Risk |
Pathogenic/Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Muscular dystrophy |
| RS1326401609 |
MAP2K1
|
Health Risk |
Likely pathogenic |
Cardiofaciocutaneous syndrome 3, Cardiofaciocutaneous syndrome 3 |
| RS1326405747 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal cell carcinoma, Hereditary cancer-predisposing syndrome |
| RS1326410920 |
APC
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS1326427792 |
GLDC
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycine encephalopathy, Glycine encephalopathy |
| RS1326445668 |
SLC12A2
|
Health Risk |
Likely pathogenic |
Kilquist syndrome, Kilquist syndrome |
| RS1326450802 |
SYN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Epilepsy, X-linked 1 |
| RS1326459816 |
LRP5
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteoporosis with pseudoglioma, Osteoporosis with pseudoglioma |
| RS1326475927 |
LRP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Donnai-Barrow syndrome, Inborn genetic diseases |
| RS1326483413 |
CAPN3
|
Health Risk |
Likely pathogenic |
Muscular dystrophy, limb-girdle |
| RS1326513178 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1326514987 |
GJB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 1A, Autosomal recessive nonsyndromic hearing loss 1A |
| RS1326526453 |
ALDH5A1
|
Health Risk |
Pathogenic |
Succinate-semialdehyde dehydrogenase deficiency, Succinate-semialdehyde dehydrogenase deficiency |
| RS1326535455 |
BUB1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Mosaic variegated aneuploidy syndrome 1 |
| RS1326546845 |
EYS
|
Health Risk |
Pathogenic |
— |
| RS1326550771 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS1326573780 |
TNPO3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant limb-girdle muscular dystrophy type 1F, Autosomal dominant limb-girdle muscular dystrophy type 1F |
| RS1326601709 |
SDHB
|
Health Risk |
Conflicting classifications of pathogenicity |
Pheochromocytoma, Gastrointestinal stromal tumor |
| RS1326604025 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Spastic paraplegia |
| RS1326606159 |
KIT
|
Health Risk |
Conflicting classifications of pathogenicity |
Gastrointestinal stromal tumor, Hereditary cancer-predisposing syndrome |
| RS1326623899 |
BCKDHA
|
Health Risk |
Conflicting classifications of pathogenicity |
Maple syrup urine disease, Maple syrup urine disease type 1A |
| RS1326631351 |
POMT2
|
Health Risk |
Pathogenic/Likely pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2 |
| RS1326635278 |
EYS
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa 25, Retinal dystrophy |
| RS1326644602 |
SMOC1
|
Health Risk |
Likely pathogenic |
Microphthalmia with limb anomalies, Microphthalmia with limb anomalies |
| RS1326644714 |
CPS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital hyperammonemia, type I |
| RS1326646197 |
XPC
|
Health Risk |
Likely pathogenic |
Xeroderma pigmentosum, group C |
| RS13266634 |
SLC30A8
|
Health Risk |
Benign; risk factor |
Diabetes mellitus type 2, susceptibility to |
| RS1326680081 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Duchenne muscular dystrophy, Dystrophin deficiency |
| RS1326688256 |
CYP11B1
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of steroid 11-beta-monooxygenase, Glucocorticoid-remediable aldosteronism |
| RS1326692199 |
PCDH15
|
Health Risk |
Pathogenic |
— |
| RS1326693946 |
P3H1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 8, Osteogenesis imperfecta type 8 |
| RS1326705217 |
RARS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Pontocerebellar hypoplasia type 6, Pontocerebellar hypoplasia type 6 |
| RS1326712142 |
BAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, BAP1-related tumor predisposition syndrome |
| RS1326731095 |
EVC
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS1326735946 |
SHANK3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1326745383 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1326764043 |
ABCG8
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |